Skip to main content
Contact Us
Subscribe
E-Edition
80°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Therapeutics Inc
(NQ:
APLT
)
6.340
+0.260 (+4.28%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Applied Therapeutics Inc
< Previous
1
2
3
4
5
Next >
Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside
July 31, 2024
William Blair has initiated coverage on Applied Therapeutics highlighting its focus on rare diseases such as galactosemia, SORD deficiency, and diabetic cardiomyopathy. With govorestat (AT-007) poised...
Via
Benzinga
CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
July 16, 2024
Via
Benzinga
Top 4 Health Care Stocks That May Keep You Up At Night This Month
June 11, 2024
Via
Benzinga
APLT Stock Earnings: Applied Therapeutics Meets EPS, Misses Revenue for Q1 2024
May 09, 2024
APLT stock results show that Applied Therapeutics met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease
April 01, 2024
FDA extends the review period for Applied Therapeutics' NDA for govorestat, targeting Classic Galactosemia treatment. The new action date is set for November 28, 2024. Applied Therapeutics anticipates...
Via
Benzinga
Exposures
Product Safety
Applied Therapeutics: Q4 Earnings Insights
March 06, 2024
Via
Benzinga
(APLT) - Analyzing Applied Therapeutics's Short Interest
January 25, 2024
Via
Benzinga
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
April 01, 2024
Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 01, 2024
Via
Benzinga
Oxford Industries Posts Weak Results, Joins Applied Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
April 01, 2024
U.S. stock futures were higher this morning, with the Dow futures gaining by over 100 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's After-Market Session
March 29, 2024
Via
Benzinga
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
March 11, 2024
U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 28, 2024
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.
Via
Benzinga
Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
February 28, 2024
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder
February 28, 2024
Applied Therapeutics surges as FDA grants Priority Review to govorestat (AT-007) for Galactosemia treatment. If approved, it would be the first medication for Galactosemia. APLT also submits MAA to...
Via
Benzinga
Exposures
Product Safety
Why Is Coupang (CPNG) Stock Up 4% Today?
February 28, 2024
Coupang stock is rallying on Wednesday as investors in CPNG celebrate the company beating out EPS and revenue estimates for Q4.
Via
InvestorPlace
Why Is Applied Therapeutics (APLT) Stock Up 59% Today?
February 28, 2024
Applied Therapeutics stock is rising higher on Wednesday alongside heavy trading of APLT following an update from the FDA.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
February 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 16, 2024
Via
Benzinga
Why Is Rare Disease-Focused Applied Therapeutics Stock Trading Higher Today?
February 15, 2024
Results of Applied Therapeutics' Phase 3 INSPIRE trial for oral govorestat (AT-007). Govorestat demonstrates significant sorbitol reduction, improving mobility and overall well-being in SORD Deficiency...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 15, 2024
Via
Benzinga
Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales
January 05, 2024
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 50 points on Friday. The Dow traded up 0.13% to 37,490.36 while the NASDAQ rose 0.25% to 14,546.77. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 05, 2024
Shares of Applied Therapeutics, Inc.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 05, 2024
Via
Benzinga
Dow Turns Lower; ISM Services PMI Falls In December
January 05, 2024
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 70 points on Friday. The Dow traded down 0.19% to 37,369.52 while the NASDAQ rose 0.16% to 14,533.16. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Applied Therapeutics' Diabetes-Associated Heart Disease Drug Fails In Phase 3 Study, Stock Plunges
January 05, 2024
Applied Therapeutics Inc (NASDAQ: APLT) released topline results of the ARISE-HF Phase 3 trial of AT-001 (caficrestat) in patients with Diabetic Cardiomyopathy (DbCM) at high risk of
Via
Benzinga
Intellia Therapeutics Layoffs 2024: What to Know About the Latest NTLA Job Cuts
January 05, 2024
Intellia Therapeutics layoffs are in the news on Friday as the biotech company prepares to cut its total workforce by 15% to reduce costs.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
US Stocks Higher; Payrolls Increase By 216,000 In December
January 05, 2024
U.S. stocks traded higher this morning, following the release of jobs data on Friday. Following the market opening Friday, the Dow traded up 0.08% to 37,470.26 while the NASDAQ rose 0.20% to 14,539.40....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Safe and Green Development (SGD) Stock Up 50% Today?
January 05, 2024
Safe and Green Development stock is up on Friday as investors in SGD celebrate the company's plans to acquire Majestic World Holdings.
Via
InvestorPlace
Why Is Applied Therapeutics (APLT) Stock Down 30% Today?
January 05, 2024
Applied Therapeutics stock is tumbling on Friday as investors react to lackluster results from a Phase 3 clinical trial of AT-001.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.